TFF Pharmaceuticals Provides Continued Positive Outcomes from Tacrolimus Inhalation Powder Phase 2 Trial for the Prevention of Lung Transplant Rejection
| TFFPDelisted Stock | USD 0.07 0.00 0.00% |
Slightly above 60% of Tff Pharmaceuticals' investor base is looking to short. The analysis of overall sentiment of trading Tff Pharmaceuticals stock suggests that many investors are alarmed at this time. Tff Pharmaceuticals' investing sentiment overview a quick insight into current market opportunities from investing in Tff Pharmaceuticals. Many technical investors use Tff Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Tff |
Patient enrollment has accelerated, now with 13 patients enrolled in trial TFF TAC at 20 percent of the oral tacrolimus dose prevented acute rejection and achieved 80 percent of the previous oral trough blood levels -- leading to diminished drug burden 9 out of 9 patients who completed the 12-week treatment chose to remain on TFF TAC by proceeding to the long-term extension Phase 2 patients have been treated for over a year and 6 patients have been treated for more than 6 months Observed a 6.5-fold
Read at finance.yahoo.com
 |
Tff Pharmaceuticals Fundamental Analysis
We analyze Tff Pharmaceuticals' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tff Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tff Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Beta
Beta Comparative Analysis
Tff Pharmaceuticals is currently under evaluation in beta category among its peers. Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
Tff Pharmaceuticals Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tff Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Tff Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Tff Pharmaceuticals by comparing valuation metrics with similar companies.
Peers
Tff Pharmaceuticals Related Equities
| INAB | In8bio | 7.69 | ||||
| GANX | Gain Therapeutics | 7.41 | ||||
| CUE | Cue Biopharma | 6.86 | ||||
| INMB | INmune Bio | 5.57 | ||||
| LTRN | Lantern Pharma | 3.45 | ||||
| QNRX | Quoin Pharmaceuticals | 3.08 | ||||
| CGTX | Cognition Therapeutics | 2.86 | ||||
| ANVS | Annovis Bio | 1.59 | ||||
| TCRX | Tscan Therapeutics | 1.33 | ||||
| DRMA | Dermata Therapeutics | 0.75 | ||||
| ANTX | AN2 Therapeutics | 0.72 | ||||
| IMNM | Immunome | 0.85 | ||||
| ANEB | Anebulo Pharmaceuticals | 5.95 | ||||
| ANIX | Anixa Biosciences | 7.20 |
Check out Tff Pharmaceuticals Hype Analysis, Tff Pharmaceuticals Correlation and Tff Pharmaceuticals Performance. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Other Consideration for investing in Tff Stock
If you are still planning to invest in Tff Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tff Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |